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Hiroyuki Furukawa, Jorge Reyes, Kareem Abu-Elmagd, 
Satoru Todo, John J. Fung, and Thomas E. Starzl 
Although the intestine was one of the first organs to be transplanted 
experimentally, clinical intestinal transplantation has been unsuccess-
ful until recently, primarily due to the absence of potent immunosup-
pressive agents. 
Lillihei et al first reported intestinal transplant in humans in 1967 (1). 
A total of seven unsuccessful intestinal transplantations were per-
formed before cyclosporine was introduced (2-5). Azathioprine, 
steroids, antilymphocyte globulin (ALG), or thoracic duct drainage 
were used for immunosuppressive therapy, but the patients died from 
technical failure, rejection, and sepsis. The longest survival was 76 days 
(5). 
These poor clinical results, as well as the advent of total parenteral 
nutrition (TPN) in the early 1970s, prevented the development of clin-
ical intestinal transplantation for more than a decade. Meanwhile, 
heart, liver, and kidney transplantation had rapidly become a more 
practical procedure, especially after the introduction of cyclosporine. 
In 1985, Cohen et al performed the first intestinal transplantation 
using cyclosporine; however, the patient survived for only 10 days (6). 
Extensive survivals were first achieved with multivisceral transplanta-
tion in 1987 by Starzl et al (7) and with combined liver and intestinal 
transplantation in 1989 by Grant et al (8) using the cyclosporine-based 
immunosuppression. However, results of the isolated intestinal trans-
plantation under cyclosporine were still unsatisfactory (6,9-15). Only 
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2 of 13 patients (15%) are currently alive with functioning grafts 
(12,15). 
Since the advent of the potent immunosuppressive agent tacrolimus 
(FK 506), intestinal transplantation has become a feasible therapeutic 
option for patients with irreversible intestinal failure (16-18). During 
the past five years, 62 patients received intestinal grafts alone, com-
bined with the liver, or as a part of multiviscera, at the University of 
Pittsburgh Medical Center. 
In this current text, we present our clinical experience with intesti-
nal transplantation, focusing on the selection and management 
of intestinal donors as well as the procurement and preservation of 
intestinal grafts. 
TYPE AND INDICATIONS OF TRANSPLANTATION 
Irreversible intestinal failure is defined as the inability to maintain 
nutrition or positive fluid and electrolyte balance without special 
support owing to the loss of absorptive surface or function of the 
native small bowel. Irreversible intestinal failure is the primary 
indication for intestinal transplantation and its causes for our 62 
patients are summarized in Table 11-1. Currently, three different types 
of intestinal transplants (isolated intestinal, combined liver and intesti-
nal, or multivisceraD can be performed, depending on the cause 
and severity of intestinal failure and the presence of extraenteric organ 
dysfunction. 
Isolated intestinal transplantation is indicated for patients who have 
irreversible intestinal failure with no other organ dysfunction. This pro-
cedure is currently performed in selected patients who lack venous 
access for TPN because of major venous thrombosis or frequent line 
sepsis. 
Table 11·1. Causes of Intestinal FaIlure 
Children No. Adults No. 
Volvulus 8 Crohn's disease 7 
Gastroschisis 7 Thrombotic disorder 7 
Necrotizing enterocolitis 6 Intestinal trauma 4 
Intestinal atresia 6 Desmoid tumor 4 
Pseudo-obstruction 3 Intestinal adhesions 3 
Microvillous inclusion disease 2 Intestinal polyposis 1 
Intestinal polyposis Pseudo-obstruction 
Hirschsprung's disease Volvulus 
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Surgical short gut syndrome, with loss of more than 80% of the small 
bowel, is the most common indication for isolated intestinal trans-
plantation. The leading causes of intestinal resection in adults include 
abdominal trauma, Crohn's disease, surgical adhesions, Gardner's syn-
drome, desmoid tumor, and occlusion of the superior mesenteric 
vessels. Causes differ in the pediatric population and include necro-
tizing enterocolitis, intestinal atresia, midgut volvulus, and compli-
cated gastroschisis. Two less common categories exist as indications 
for isolated intestinal transplantation. The first is chronic pseudo-
obstruction, which is manifested by defective gastrointestinal motility 
due to either hollow visceral myopathy, neuropathy, or total intestinal 
aganglionosis. The second is impairment of absorptive and secretory 
capacity of the enterocyte to indicate permanent TPN therapy in 
patients with microvillous inclusion disease, autoimmune enteropathy, 
radiation enteritis, extensive inflammatory bowel disease, and massive 
intestinal polyposis. 
Combined liver and intestinal transplantation is primarily indicated 
for patients who suffer from intestinal failure with TPN-related 
cholestatic liver failure. It is also the procedure of choice for patients 
with liver failure and concomitant thrombosis of the entire portomes-
enteric system. In these patients, enterectomy of the normally func-
tioning native intestine is required. Simultaneous liver replacement, 
despite absence of the liver failure, is indicated only in patients with 
vascular thrombosis due to congenital coagulation defects (protein C 
or 5, or antithrombin III deficiency). In some of these patients, multi-
visceral transplantation is inevitable because of concomitant vascular 
insufficiency of the remaining upper abdominal organs, including the 
stomach, duodenum, and pancreas. 
Multivisceral transplantation is indicated for patients with irre-
versible failure of more than two of the abdominal visceral organs 
including the intestine. Generally, the liver, pancreas, stomach, duode-
num, and intestine are implanted. The liver can be omitted from mul-
tiviscera if the patient has a normal native liver. 
The common causes for these multi visceral failures are extensive 
thrombosis of the splanchnic vessels, massive gastrointestinal poly-
posis, and generalized chronic pseudo-obstruction. Multivisceral 
transplantation can also be attempted for patients with potentially 
curable abdominal malignancies that require upper abdominal exen-
teration. 
Currently, intestinal transplantation is contraindicated for patients 
with significant cardiopulmonary insufficiency, history or presence of 
aggressive and incurable malignancy, persistent abdominal or systemic 
infection, and extensive atherosclerosis or severe autoimmune and 
immunodeficiency syndromes. Also, senior citizens E~SM yr), patients 
with an inactive lifestyle, and those who failed alcohol or drug reha-






224 Chapter I I 
RECIPIENT OPERATION AND MANAGEMENT 
An understanding of the recipient operation is important in perform-
ing the flexible procurement of intestinal grafts. The principles and 
details of the recipient operations have been described elsewhere 
(16-20). All recipients receive routine gut decontamination and intra-
venous antibiotics prophylactically. 
In isolated intestinal transplantation, the superior mesenteric artery 
of the graft is anastomosed to the anterior wall of the recipient 
infrarenal aorta (Fig. 11-1). The venous outflow of the intestinal graft 
is drained into the recipient portovenous system in most cases; in a few 
instances, the recipient portal vein is anastomosed to the do~or infe-
rior vena cava. The proximal jejunum of the graft is anastomosed to 
either the jejunum or duodenum of the recipient. Distal anastomosis is 
done in patients who still have their native rectosigmoid colon. The 
donor ileum or donor colon is connected to the recipient colon with 
Figure 11·1. Isolated Intestinal transplantation Including one-half of the 
colon (mam figurel or the small intestine only (left Insert). Graft venous flow IS 
drained end to side Imam figure) or end to end rIght Insert) Into the host 
portal system. IVC = Inferror vena cava. IReproduced by permission from Abu-
Elmagd K. Todo S. Tzakls A et al Three years' clinical expenence With InteStinal 
transplant<"1tlon J Am Col Surg 1994; 179 385-400) 
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creation of the simple enterostomy or Bishop-Koop ileostomy. Con-
struction of the temporary enterostomy facilitates clinical, endoscopic, 
and histologic monitoring of the graft. The Bishop-Koop ileostomy is 
performed in patients who receive the colon as part of the intestinal 
graft to provide easy access for ileoscopy. Terminal ileostomy or 
colostomy is performed in most of the patients who have lost their 
native rectosigmoid colon. 
In combined intestinal and liver transplantation, the hepatic venous 
flow is reconstructed by the piggyback technique (21) (Fig. 11-2). The 
common arterial conduit of the entire graft is anastomosed to the recip-
ient infrarenal aorta (Fig. 11-3). After reperfusion, the previously per-
formed portocaval shunt is converted to a portoportal shunt by 
reanastomosing the recipient portal vein to the side of the graft portal 
vein (22). In patients whose portal vein is too short, or when the graft 
portal vein is too small, the recipient portocaval shunt is left in place 
permanently (see Fig. 11-2, right insert). The biliary tract of the new 
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Figure 11-2. Combined liver and Intestinal transplantation Including part of 
the colon (main figure! or With small Intestine only (left Insertj IS shown. The 
host portal vein (PVI IS drained Into the graft portal vein If possible Otherwise. 
this blood IS diverted IntO the vena cava (nght Insert) SMA = superior 
mesenteriC artery. CA = cellae c1rtery /Reproduced by permiSSion from Abu-Elmagd K. 
Todo S. Tzakls A. et al Three years clinical expenence With Intestinal transplantation JAm 
Col Surg 1994.179385-4001 
I 
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Figure 11·3. Arterial anastomosIs of the combined liver and Inrestlnal and multivisceral transplanratlon. 
Aortic condUit (left) In most of the recIpient. Aortic bifurcation conduit (mldd/ej and whole-abdominal aorta 
(nghq are variations. IMA = Inferior mesenteric artery. (Reproduced by permission from Furukawa H, Abu-Elmagd 
K. Reyes J. Technical aspects of intestinal transplantation. In Braverman MH. Tawe RL eds. Surgical technology 
International 2 San FranCISco Surgical Technology International, 1993: 165-1 70.1 
anastomosis, Continuity of the gastrointestinal tract is established in a 
fashion similar to that described for the isolated intestinal graft. 
In multivisceral transplantation, as with the combined (liver-
intestine) graft, vascular reconstruction includes both hepatic venous 
and graft arterial anastomoses (Fig. 11-4), The graft suprahepatic cava 
is anastomosed to the recipient hepatic veins (piggyback), The arterial 
conduit is anastomosed to the recipient celiac or infrarenal aorta. Prox-
imal reconstruction of the alimentary tract is established by anasto-
mosing the distal esophagus or the remaining portion of the stomach 
of the recipient to the anterior gastric wall of the graft. Distal continu-
ity of the intestinal tract is established in the same way as isolated and 
combined intestinal grafts. 
Postoperative immunosuppression is achieved with tacrolimus 
(FK 506), steroids, and, in selected cases, azathioprine. Recovery of 
intestinal graft function is assessed primarily by serial gastrointestinal 
radiographs, FK 506 oral pharmacokinetics, and D-xylose absorption 
test. Frequent anthropometric measures, serial serum albumin mea-
surements, and trace element and fatty acid analyses are assessed to 
monitor and direct the nutritional management of these cases. 
Intestinal allograft rejection is monitored using clinical, endoscopic, 
and histopathologic parameters. Surveillance endoscopy with multiple 
mucosal biopsies is performed once or twice a week for the first 3 
months, and thereafter whenever it is clinically indicated. Acute graft 
rejection is treated either by augmenting tacrolimus (FK 506) therapy, 
steroid bolus, steroid recycle, or OKT3 based on the severity of the 
rejection episode (23). 
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Figure 11-4. Muitivisceral transplantation Including the ascending and nght 
transverse colon, Note that pyloroplasty or pyloromyotomy IS performed and 
the bile flow IS temporarily decompressed (Reproduced by permiSSion from Abu. 
Elmagd K, Todo S. Tzakls A. et al. Three years clinical expertence With Intestinal 
transplantation J Am Co! Surg 1994'179385-4001 
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SELECTION AND MANAGEMENT OF DONORS 
Grafts for intestinal transplantation are obtained from cadaveric 
donors. The general criteria for donor selection do not differ from those 
for liver donors. Young «45 yr old), hemodynamically stable, local 
donors are preferred. Since the intestine is very sensitive to ischemia, 
a donor who has had a high dose of vasopressor agents or has a history 
of hypotension of long duration, cardiac arrest, and/or cardiopul-
monary resuscitation should be avoided. Those with systemic infection 
and malignancy are also excluded. Donor size should be similar to or 
preferably smaller than that of the recipient, whose peritoneal cavity 
is usually shrunk secondary to previous repeated surgeries. ABO 
blood type should be identical between donor and recipient. Human 
leukocyte antigen (HLA) matching is not currently considered and is 
universally poor. Ideally, donors with positive lymphocytotoxic cross-
match should be excluded. This policy is not presently applied at our 
institute because of the possibility of jeopardizing the donor organ by 
prolonged cold ischemia while waiting for the crossmatch result. No 
attempts are made to alter the graft lymphoreticular tissue with anti-
lymphocyte preparations or other modalities. Cytomegaloviral (CMV)-
seronegative donors are selected for all intestinal recipients. This policy 
was recently adopted to reduce the incidence of CMV disease, since 
recipients who receive CMV-seropositive grafts have significant high 
mortality (24). 
All donors receive routine gut decontamination. The antimicrobial 
agents used are amphotericin B/nystatin (Mycostatin), aminoglyco-
sides, and polymyxin E through a nasogastric tube. At the same time, 
ampicillin and cefotaxime are given intravenously every 6 to 8 hours 
and at the time of organ procurement. 
The University of Wisconsin (UW) solution is used for in situ perfu-
sion and simple cold storage of the entire graft. The total volume of the 
UW solution used for in situ perfusion is 1 to 2 liters for adult donors 
and 50 to 100 mL/kg for pediatric donors. When the colon is not 
included in the intestinal graft, no attempt is made to flush the lumen 
of the intestinal graft with UW or other cold solutions. When the colon 
is part of the intestinal graft, the lumen is flushed with 1 to 2 liters of 
chilled lactated Ringer's solution containing amphotericin B, amino-
glycosides, and polymyxin. 
DONOR OPERATIONS 
A key factor in successful intestinal transplantation is the procurement 
of intestinal grafts of good quality and satisfactory anatomy. Anatomic 
:"~ .;. i ~K 
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considerations are particularly essential at the time of intestinal pro-
curement because the recipients require different types of intestinal 
transplantation, depending on the severity of extraenteric organ dys-
function. The logistics of the operative procedure have been described 
previously (19,20,25). 
Isolated Intestine 
The retrieval procedure starts with a cruciate abdominal incision (Fig. 
n-5). The greater omentum is carefully dissected and separated from 
the trans\'erse mesocolon. After the duodenum is kocherized, the 
cecum, ascending colon, and mesenterium are mobilized from the 
retroperitoneum. The right and middle colic vessels and appendiceal 
vessels are divided, sparing the ileal branches of the ileocolic artery. 
The ileum is divided at the ileocecal valve before the cross clamp. 
Attention is then directed to the proximal jejunum, which is tran-
sec ted close to the ligament of Treitz. The third and fourth portion of 
Figure 11·5. A Isolated Intestlnai graft Without cOlon full-length vascular pedicle of the super/or 
mesenteriC artery iSMA, Wltn Carrel patcl'l) and vein ISMV! Imaln figure) Note that the Iliac artenal graft 
was used 3S an extension of the superior mesenteric artery (ngll[ Inserri PV = portal vein !FZeprOduced b\ 
permlpplo~ from Tooo S TZclkis AG Atlr-~lmago K. et a: Intestlna, transPlantation In compoSIte visceral grafts or ,llone 
Ann Surg 1992,216223-234 I 8, Graft With colon (Reoroduce'J by permiSSion from Furukawa H, Abu-Elmago K, 
Reyes j Technical asoects of Inrestlnal rranso,anratron In Sraverr'"kln MH, Tawe RL, eas purgfCI~: teChnology 
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uw 
Figure 11-6. In situ perfusion with UW solution through both abdominal 
aorta and portal vein In multlVlsceral procurement the gr<lft IS perfused only 
through the abdominal aorta. UW = University of Wisconsin solution. CA = 
celiac artery: SMA = superior mesenteric artery: IMA = Inferior mesenteric artery: 
PV = portal vein. 
" . 
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the duodenum with the attached proximal jejunal segment are further 
mobilized and dissected from the root of the mesenterium by dividing 
the small numerous branches behveen the superior mesenteric vessels 
and the duodenum as well as the pancreas. 
In a nonpancreatic donor, the portal and superior mesenteric veins 
are exposed by transecting the pylorus and the neck of the pancreas. 
After the anterior surface of the portal and superior mesenteric veins 
are exposed, the lateral and posterior walls are dissected from the 
pancreas and duodenum by interrupting the pancreatic and duodenal 
tributaries. Meanwhile, a short segment of the splenic vein at the 
confluence is dissected and encircled for future cannulation. The 
infrarenal aorta is dissected toward the bifurcation of the common iliac 
arteries. The distal abdominal aorta and the splenic vein are cannulated 
after systemic heparinization of the donor. After the supraceliac or 
thoracic aorta is cross clamped, the abdominal aorta and portal 
vein are individually perfused with an adjusted volume of UW 
solution (Fig. 11-6). To separate the liver from the intestine, the portal 
vein is transected above the confluence of the superior mesenteric and 
splenic veins. The liver graft is then retrieved using the standard tech-
nique (26,27). For the intestinal graft, a Carrel patch is fashioned con-
taining the origin of the superior mesenteric artery on the aorta. The 
intestine is then removed and immersed in the UW solution. In cases 
that require a vascular conduit, the arterial or venous grafts, or both, 
are anastomosed to the graft superior mesenteric artery and vein on 
the back table. 
In a pancreatic donor, both the superior mesenteric artery and vein 
are completely dissected and isolated just above the origin of the 
middle colic vessels. After perfusion, the superior mesenteric vessels 
and inferior mesenteric artery are divided, and the intestinal graft is 
removed. The organs are then placed immediately in a plastic bag con-
taining cold UW solution, packed in an ice container, and transferred 
to the recipient hospital. 
VARIATION TO INCLUDE THE COLON 
Additional colon retrieval is possible depending on the recIpIent 
requirements. This variation is also applied to combined liver and 
intestinal, or multi"isceral procurement. In addition to the cecum, 
ascending colon, and mesenterium, descending colon is mobilized 
from the retroperitoneum. Before cross clamp, the origin of the inferior 
mesenteric artery is carefully identified. The sigmoid colon is then tran-
sected after mobilization by dissecting the mesocolon down to the rec-
tosigmoid junction. After cross clamp, the inferior mesenteric artery is 
preserved and procured using the Carrel patch technique. 
• 
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Intestine Combined with Liver 
After the abdominal cavity is entered, the liver is mobilized by divid-
ing its ligaments (Fig. 11-7). The gallblodder is incised following tran-
section of the common bile duct, and the bile is washed out. The portal 
vein is exposed after dividing the right gastric and gastroduodenal 
arteries. The left gastric and splentic arteries are then identified and 
divided. The remaining steps of mobilizing and dissecting the intesti-
nal portion of the graft are the same as those used to retrieve the iso-
lated intestinal graft in a non pancreatic donor. It is important to 
Figure 11-7. Combined liver and Intestinal graft A. Without colon /ReprOduced by permission from Todo 
S. Tzakls AG. Abu·Elm,;gd K. et .'II Intestinal :ramplantatlon In composite visceral grafts or "lone Ann Surg 
: 992.216 22 3-234) B. With colon. (Reproduced by permission from Furukawa H. Abu·Elmagd K. Reyes J Technical 
"spects of Incestlnal transplantation In Braverman MH. qI~we RL. eds. SurgICal technology International 2 San 
FranCISco Surgical Technology Internat:onal. 1993 165-170, Carrel patch Including celkK aXIs (CA) and superior 
mesenteriC artery ISMA) Note the continuity of donor portal vein IVC = Inferior vena cava. 
::i· ~K ~KI _ . . . . .' - .,....., . 
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emphasize that the pancreas must be sacrificed in order to procure the 
liver and intestinal grafts en bloc. Complete dissection and separation 
of the superior mesenteric vessels from the duodenum and pancreas 
are carried out on the back table. 
After cross clamping, buth the infrarenal aorta and the portal vein 
are individually perfused with the adjusted volume of UW solution. A 
Carrel patch is fashioned, containing the origins of both the celiac axis 
and superior mesenteric artery on the aorta. The infrahepatic vena cava 
is transected above the renal veins. The organs are removed en bloc 
and placed in the standard plastic bag containing cold UW solution, 
and packed in the ice container for transportation. 
On the back table, the suprahepatic and infrahepatic vena cava are 
fashioned in the same way as for liver transplantation. After proper ori-
entation of the vascular structures of the graft, both the pancreatic head 
and duodenum are carefully dissected and separated from the graft. 
After both the celiac axis and the superior mesenteric artery are dis-
sected down to the origin of the middle colic artery, the Carrel patch is 
anastomosed to a suitable aortic graft as a common vascular conduit 
(see Fig. 11-3). 
Intestine as Part of Multivisceral Graft 
Retrieval of the multivisceral graft, which includes the stomach, duo-
denum, pancreas, intestine, and liver, is a unique technical procedure 
(Fig. 11-8). The greater gastric curvature is devascularized with preser-
vation of the gastroepiploic arch. The short gastric vessels are ligated 
and interrupted, and the greater omentum is resected. The remaining 
steps of mobilizing and dissecting the intestinal portion of the graft are 
the same as those used to retrieve the isolated intestinal graft in a non-
pancreatic donor. Splenectomy is done either in situ or on the back 
table. In situ splenectomy is performed after complete mobilization of 
both the spleen and pancreas from the retroperitoneal structures with 
interruption of the splenocolic ligament. Meticulous dissection of the 
splenic hilus and individual ligation of the splenic vessels is manda-
tory to avoid injury of the pancreatic tail. The esophagogastric junction 
is transected using the stapler technique. The multivisceral graft is per-
fused ollly through the distal abdominal aorta with one to two liters of 
UW solution. The back table procedure, with dissection of suprahep-
atic and infra hepatic vena cava, is the same as in liver transplantation. 
The celiac axis and the root of the superior mesenteric artery are dis-
sected and isolated while the surrounding lymph nodes, ganglion, and 
nerves are removed. The Carrel patch is anastomosed to a suitable 
aortic graft as a common vascular conduit. Pyloroplasty or pyloromy-
otomy is performed either on the back table or after implantation of 
the graft. 
, 
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A B 
Figure 11-8. Multivisceral graft A. Without colon. IReproduced by permission from Todo S. 
Tzakls AG. AbvElmagc K. et al. Intestinal transplantation In composite visceral grafts or alor,e Ann Surg 
1992.2 I 6223-234 j B With colon. IReproduced by permission from FuruKav.-a f-'. Abu-Eimc1gd K. Reyes j Technical 
asoects of If:test:nal :ransplantatlon In Braverman MH. Tawe RL. eds Surgical recnnology InternatiOnal 2 San 
F'anciSCo Sc.rqcal Tecnnology International. 1993.165-170 I Carrel patch Including celiac aXIs (CA) and superior 
mesenteric clr:ery (SMA) Splenectomy was performed dUring donor operation or on the bclCk table 
VARIATION OF THE SURGICAL TECHNIQUES 
Our cumulative surgical experience with intestinal transplantation dic-
tated subsequent modification of donor operative techniques. 
With increaSing demands for additional organ replacement at the 
time of transplantation for some recipients, the multivisceral retrieval 
has been adopted for cases with extended thrombosis of the splanch-
nic vessels, disease with uncertain extension (active Crohn's disease, 
pseudo-obstruction, and total aganglionosis), marginal liver function, 
and history of pancreatitis. These patients might require additional 
, --, . -. . ; ··t~~ 
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organs, such as the liver, pancreas, and stomach, in addition to the 
expected organ requirement. The graft is then tailored on the back table 
according to the organs that it will replace (28) (Fig. 11-9). 
The feasibility of the vascular and enteric anastomoses with preser-
vation of the ileocecal valve by transplanting part of the donor colon 
has been proved. A pullthrough operation was performed in two pedi-
atric recipients to preserve the anorectal sphincters. Retrieval of the 
entire colon down to the rectosigmoid is required with preservation 
of its marginal blood supply including the inferior mesenteric arcade 
(29). 
However, recent analysis shows that the inclusion of the colon in 
intestinal grafts worsens graft outcome. This poor outcome is due 
to graft rejection occurring in the early postoperative period. These 
findings suggest that only small intestine or a short segment of 
the colon preserving the ileocecal valve should be included in the graft 
(30). 
In one of our multi visceral recipients, the native liver was preserved 
and the retrieved liver was separated from the multivisceral graft and 
given to a second recipient. Technically, the liver is separated from the 
graft by dissecting and transecting the common hepatic artery below 
the origin of the gastroduodenal artery and the portal vein above the 
confluence of the splenic and superior mesenteric veins on the back 
table. 
Figure 11·9. Multivisceral graft ilefrl car be transformed to combined liver and Intestinal graft (mICldle) 
by removing stomach. duodenum and pancreas. LJver and Inrestlnal graft can be diVided to liver and 
Isolated Intestine (right) 
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INTESTINAL PRESERVATION 
Maintaining the morphologic and functional integrity of the intestinal 
grafts during the time interval from cross clamp to postreperfusion 
period is essential for intestinal preservation. University of Wisconsin 
solution has been applied to successful clinical intestinal transplanta-
tion. Although this solution has been proven to allow extended cold 
storage of the liver (31-33), pancreas (34), and kidney (35) in both 
animals and humans, the limit of intestinal storage with UW solution 
has not yet been determined. Therefore, the intestine is currently trans-
planted as soon as possible after retrieval. If a preservation method 
would allow the intestinal graft to function after an ischemia time of 
12 to 24 hours, more organs would be available from more distant 
cities, and unnecessarily rushed donor and recipient surgery could be 
avoided. Close scrutiny of the graft would even be possible before the 
recipient surgery was begun. 
In his early experiments, Lillihei first documented the safe limit of a 
complete in vivo interruption of intestinal circulation in dogs (36). The 
small bowel tolerates 2 hours of total ischemia if the bowel is allowed 
to cool to room temperature (25°-28°e). If the bowel is cooled to SoC, 
it is safe to interrupt its circulation completely for at least 5 hours. Addi-
tion of chlorpromazine to the storage solution or hyperbaric oxygen, 
or both, allows successful preservation at 2° to 4°C for 24 and 48 hours, 
respectively (37,38). The development of continuous machine perfu-
sion permits preservation of intestinal grafts for 18 hours in vitro (39). 
Perfusion preservation with Collins solution, dog plasma, or human 
plasmanate is used in autotransplantation in dogs and allows preser-
vation for 24 hours (40AO. However, since both hyperbaric oxygen 
and continuous machine perfusion are very complicated for clinical 
usage, simple cold storage is widely used along with the improve-
ment of preservation solutions. Various preservation solutions have 
been tested, comparing survival, histology, mucosal enzyme activity, 
mucosal high-energy phosphate, and motility function in animals. 
Preservation of the small intestinal grafts with UW solution for 12 to 
48 hours allows 679c to 100% survival in rats (42-44). Although some 
discrepancies exist with high-energy phosphate level of the mucosa in 
the nonsurvival studies using UW solution (45,46), LJW solution seems 
to be superior in survival as well as motility function (42). 
The techniques of perfusion and reperfusion of the intestinal grafts 
represent an important factor in intestinal preservation. The addition 
of luminal flushing to the standard vascular flushing of intestinal grafts 
improves the survival of dogs receiving 24-hour preserved small bowel 
grafts from 0 to 809c (47). A beneficial effect of the vascular washout 
(4°C saline) and topical rewarming at the time of reperfusion has been 
studied. Rats that received 12-hour preserved small intestine under 
extracellular fluid without vascular washout, with topical rewarming, 
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have significantly better survival (67%) than the other groups 
07%-33%) (44). 
In clinical intestinal transplantation in Pittsburgh, UW solution has 
been used for all grafts except the isolated intestinal graft, which was 
excised and simply immersed in cold lactated Ringer's solution. The 
cold ischemia time for all grafts ranged from 2.8 to 12.1 hours with a 
mean of 7.6 hours. These relatively short cold ischemia times reflect our 
adopted policy by utilizing local donors, and coordinating the timing 
for the donor and recipient operation. 
Ischemic and preservation injury are clinically and histologically 
documented in most grafts (48). Although none of the intestinal grafts 
have been lost from ischemic and preservation injury, the following two 
incidents might be related to the same mechanism. In one of the mul-
tivisceral grafts, the small intestine had multiple perforations with 
intramucosal to transmural coagulative necrosis in the antimesenteric 
portion of the small intestinal wall 10 to 25 days after transplantation, 
which required multiple intestinal resections. In one of the combined 
liver and intestinal grafts, a solitary perforation was found at the 
splenic flexure of the transverse colon in the antimesenteric border 15 
days after transplantation. The loop colostomy was performed, and 
was later closed. Both grafts had relatively long cold ischemia time, 8.2 
and 11.4 hours, respectively. Ischemia from perioperative phenyle-
phrine hydrochloride infusion in the first case, and prolonged car-
diopulmonary resuscitation before procurement in the second case, 
were suspected as causes. 
CURRENT RESULTS 
Of the 62 recipients, 31 (50 Gle) are currently alive 9 to 55 months after 
intestinal transplantation. The main causes of death are rejection, infec-
tion, and posttransplant lymphoproliferative disorder (PTLD). Of the 
31 current survivors, 25 (80o/d patients are free of TPN and enjoying an 
unrestricted oral diet (Table 11-2). 
Table 11·2. Current Status of Intestinal Transplantation 
Median Patients 
Type of Follow-up Patient Graft Patients TPN 
Graft Imol Survival Survival at Home Free 
lsolatE-d 19 <O.i-4Ol 12122 (54.5';; , 8/24 03.3'ic) 11 /12 8112 
mtestine 
Liver and 21 <0.7-55) 14/29 (48.37,) 14/31 (45.2";;) 13/14 Bi14 
mtestine 
\1ulti\'isceral 21 (1.&-40) ;/ll (45.50;) 5/11 (45.5";) 5/5 4/5 
-----------------
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